NAGE

Niagen Bioscience Inc (NAGE)

Healthcare • NASDAQ$3.45+2.07%

Key Fundamentals
Symbol
NAGE
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Price
$3.45
Daily Change
+2.07%
Market Cap
$278.76M
Trailing P/E
16.67
Forward P/E
10.94
52W High
$14.69
52W Low
$3.35
Analyst Target
$12.60
Dividend Yield
N/A
Beta
2.06
About Niagen Bioscience Inc

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU N

Company website

Research NAGE on Stk-Ai

Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.

Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.

Not financial advice. Pricing · Terms · Privacy · ·

Loading...